Cannabis Bioscience International Holdings Announces Effectiveness of Form S-1 Registration Statement

​​HOUSTON, TX – (NewMediaWire) – December 06, 2023 –  Cannabis Bioscience International Holdings, Inc. (OTC Pink: CBIH) announces that its registration statement on Form S-1 (File No. 333-267039) (the “Registration Statement”), filed under the Securities Act of 1933 (the “Securities Act”), was declared effective by the United States Securities and Exchange Commission (the “SEC”) on December 5, 2023. This declaration does not imply that the SEC has approved or disapproved the offer or sale of the common stock offered by the prospectus that is part of the registration statement (the “Prospectus”) or determined whether the Prospectus is truthful or complete. The Company filed the Registration Statement to register the offer and sale of 10,087,154,885 shares of its common stock at a price of $0.0008 per share. The Company is offering 6,250,000,000 of these shares and the remaining 3,837,154,885 shares may be offered by selling stockholders. The Company will receive none of the proceeds of sales by the selling stockholders. The Company has become a reporting company under Section 15(d) of the Securities Exchange Act of 1934 and is required to file annual, quarterly and other reports with the SEC thereunder. These reports will be available at“We are pleased that the SEC has declared our registration statement effective, which represents a significant milestone in our history, as we continue to develop our business,” said Henry Levinski, VP and Treasurer.The Company, headquartered in Houston, Texas, offers services in clinical trials and through Alpha Research Institute and cannabis-related education in classrooms, seminars and online through Pharmacology University. It intends to conduct clinical trials of its own cannabidiol products and to sell them.Copies of the Prospectus may be obtained on the SEC’s website at, by mail at Cannabis Bioscience International Holdings, Inc., 6201 Bonhomme Rd, Suite 466S, Houston, TX 77036, by phone at (214) 733-0868 or e-mail at ir@cbih.netThis press release does not constitute an offer to sell or the solicitation of an offer to buy any of the securities described herein, nor shall there be any sale of these securities in any state or other jurisdiction in which such an offer, solicitation or sale would be unlawful prior to registration or qualification under the securities laws of any such state or other jurisdiction.FORWARD-LOOKING STATEMENTSStatements in this press release that are not historical facts are forward-looking statements made pursuant to the safe harbor provisions of the Private Securities Litigation Reform Act of 1995, which reflect management’s current expectations, assumptions, and estimates of future operations, performance and economic conditions, and involve risks and uncertainties that could cause actual results to differ materially from those anticipated by the statements made herein. Forward-looking statements are generally identifiable by the use of forward-looking terminology such as “believe,” “expects,” “may,” “looks to,” “will,” “should,” “plan,” “intend,” “on condition,” “target,” “see,” “potential,” “estimates,” “preliminary,” or “anticipates” or the negative thereof or comparable terminology, or by discussion of strategy or goals or other future events, circumstances, or effects. Factors that could cause actual results to differ materially from those expressed or implied in any forward-looking statements in this release include, but are not limited to, the risk factors set forth in the Registration Statement, statements regarding the offer and sale of securities and the terms thereof, statements about the effects of the COVID-19 pandemic on our business and the U.S. and global economies generally; our expectations regarding our financial performance; our expectations regarding future operating performance; our ability to attract and retain customers; our ability to compete in our industries; our ability to meet our liquidity needs; our ability to … 

Related Post
Innovation Newsletter
Don't miss the most important news about Innovation. Sign up to receive them by email.  

Innovation Newsletter
Don't miss the most important news about Innovation. Sign up to receive them by email.

Recent Posts

QRyde Unveils Next-Generation Microtransit Software

QRyde, a leading innovator in public transportation software solutions, today announced the launch of its next-generation Microtransit Software. This cutting-edge…

10 hours ago

BanteyBanatey Announces the Newest Array of Art and Craft Supplies

In a thrilling announcement, BanteyBanatey, the premier online haven for art and craft aficionados, proudly unveils its latest treasure trove…

10 hours ago

Vanderbilt University women s basketball team joins the Nation of Lifesavers

​​NASHVILLE, Feb. 26, 2024 — On Wednesday, Feb. 21 at the on campus Memorial Gymnasium, members of the Vanderbilt University…

11 hours ago

Introducing ‘The Day Before Tomorrow’ – A Captivating Novel by Author Monique Britten

CALGARY, Alberta, Canada, Feb. 26, 2024 (SEND2PRESS NEWSWIRE) — In the heart of a once-sleepy farming community, a tale of…

12 hours ago

BioElectronics Corporation Announces the Publication of Pilot Study Results

​​Beneficial Treatment Effect for Phantom and Residual Limb Pain IdentifiedFREDERICK, MD - (NewMediaWire) - February 23, 2024 - BioElectronics Corporation ( OTC:…

4 days ago

Times BPO reveals how to launch a successful business in 2024

Times BPO, a leading Business Process Outsourcing company, has announced its new initiative to help aspiring entrepreneurs launch their own…

5 days ago


Innovation Newsletter
Don't miss the most important news about Innovation. Sign up to receive them by email.